Yang et al. (2008) also reported that elevated expression of LAPTM4B is associated with advanced tumor stage, and it is neither correlated with age not with gender in 85 ovarian cancer tissue samples which shows that LAPTM4B overexpression is linked with ovarian cancer progression. This evidence concerns the gene LAPTM4B and ovarian carcinoma.